top of page


Since our founding in 2017, our company has worked with many Fortune 500 companies and has partnered with many organizations and key strategic investors.

Strategic Investors

Equity partners have invested a total of $10 million and we are currently seeking an additional $2 million to close our Series A funding round. 

Screen Shot 2021-10-03 at 9.23.31 AM.png

Dreamtech has been our strategic investor and partner since 2018. Dreamtech is supporting NanoScent's electronic hardware components. In a statement from Dreamtech's CEO, Hyoung Min Kim believes “both companies are committed to the successful commercialization of ‘scent reader’ solutions worldwide... both companies will further strengthen the strategic partnership become a leading company in the healthcare market.”

In the news:

Screen Shot 2021-10-03 at 9.30.25 AM.png

Since 2019, Sumitomo Chemical is one of our key strategic investors. Sumitomo Chemical took an interest in us because they see that a rapid diagnostic sensor has great long-term potential for other applications, in addition to COVID-19. Sumitomo Chemicals is backing us up so that we can reach our goals for scaling up and manufacturing chemical electronic components.

In the news:

Grants & Projects

Through grants and projects with Fortune 500 companies, we have raised about $9 million in non-dilutive funding. 


European Innovation

The European Innovation Council supports NanoScent's project for developing a COVID-19 sensor. 


Israel Innovation

The Israel Innovation Authority has been supportive through their COVID-19 research grant.


Read More:

Forbes 500

Grants and projects with Fortune 500 companies also help drive our innovation and R&D efforts.


Read More:

bottom of page